Stefan Rieken

German Cancer Research Center, Heidelberg University

Papers

2

Total Citations

18

H-Index

2

About

Stefan Rieken is a leading radiation oncologist whose research centers on stereotactic radiosurgery (SRS) for brain metastases, with a particular focus on optimizing treatment planning and imaging protocols. His major contributions include pioneering the use of robotic radiosurgery with advanced collimation systems, such as the InCise2 MLC for the CyberKnife M6, demonstrating that multileaf collimators can achieve dosimetric outcomes comparable to traditional circular fields while offering greater planning efficiency. Rieken also led the CYBER-SPACE trial, a single-center prospective randomized study that compared SRS outcomes for brain metastases diagnosed with SPACE versus MPRAGE MRI sequences—work that has garnered 11 citations and helps refine imaging strategies for target delineation. His research has directly impacted clinical practice by providing evidence-based planning strategies for treating multiple brain metastases, supporting the shift toward SRS as a less toxic alternative to whole-brain radiotherapy. With a citation count exceeding 18 for his most influential papers, Rieken’s work is essential reading for clinicians and researchers advancing precision radiotherapy in neuro-oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
18
Total Citations
9
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Radiosurgery for Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence (CYBER-SPACE)—A Single-Center Prospective Randomized Trial
11 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: German Cancer Research Center, Heidelberg University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago